Artelo Biosciences, Inc. (NASDAQ:ARTL) on Monday announced new research published in the peer-reviewed Journal of ...

George Warren, PhD, Lead Author and Principal Scientist at Artelo, said, “We are excited to share the results on this novel target in psoriasis. Our findings demonstrate that ART26.12 has effects ...

There's now lots of evidence which shows that our own diets and the foods we eat can influence the outcome if we are unlucky ...

Excess linoleic acid is delivered throughout the body by a protein called FABP5, which overstimulates the mTORC1 in cells, promoting tumor growth. Researchers measured levels of FABP5 across various ...

In the study, published March 14 in Science, the researchers found that linoleic acid can activate a major growth pathway in tumor cells by binding to a protein called FABP5. Comparing breast ...

The secret lies in a protein called FABP5. FABP5 acts as a fatty acid transporter. In triple-negative tumors, cells make high amounts of this protein. The researchers found that linoleic acid ...

This activation depends on a protein called FABP5, which acts as a lipid chaperone. When omega-6 linoleic acid binds to FABP5, it activates mTORC1, which then drives cell growth and proliferation.

High expression of FABP5 promotes fatty acid metabolism through lipolysis and de novo fatty acid synthesis in prostate and breast cancer cells. Activation of PKC and increase in ROS levels by ...

In the study, published March 14 in Science, the researchers found that linoleic acid can activate a major growth pathway in tumor cells by binding to a protein called FABP5. Comparing breast ...

In the study, published March 14 in Science, the researchers found that linoleic acid can activate a major growth pathway in tumor cells by binding to a protein called FABP5. Comparing breast cancer ...